sulfamethoxazole has been researched along with Insulin Resistance in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wright, AD | 1 |
| Hartog, M | 1 |
| Palter, H | 1 |
| Tevaarwerk, G | 1 |
| Doyle, FH | 1 |
| Arnot, R | 1 |
| Joplin, GF | 1 |
| Fraser, TR | 1 |
1 other study available for sulfamethoxazole and Insulin Resistance
| Article | Year |
|---|---|
The use of yttrium 90 implantation in the treatment of acromegaly.
Topics: Acromegaly; Biguanides; Cerebrospinal Fluid Rhinorrhea; Cloxacillin; Diabetes Insipidus; Gold Isotop | 1970 |